Guida, C., Evangelista, L., Spadafora, M., Facchini, G., & Mansi, L. (2026). Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer. Cancers, 18(11), 1799. https://doi.org/10.3390/cancers18111799
Chicago Style (17th ed.) CitationGuida, Cesare, Laura Evangelista, Marco Spadafora, Gaetano Facchini, and Luigi Mansi. "Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer." Cancers 18, no. 11 (2026): 1799. https://doi.org/10.3390/cancers18111799.
MLA (9th ed.) CitationGuida, Cesare, et al. "Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer." Cancers, vol. 18, no. 11, 2026, p. 1799, https://doi.org/10.3390/cancers18111799.
Warning: These citations may not always be 100% accurate.